Circulating sCD14 is associated with virological response to pegylated-interferon-alpha/ribavirin treatment in HIV/HCV co-infected patients.

Circulating sCD14 is associated with virological response to pegylated-interferon-alpha/ribavirin treatment in HIV/HCV co-infected patients.

Microbial translocation (MT) through the gut accounts for immune activation and CD4+ loss in HIV and may influence HCV disease progression in HIV/HCV co-infection. We asked whether increased MT and immune activation may hamper anti-HCV response in HIV/HCV patients.98 HIV/HCV patients who received pe...

Full description

Bibliographic Details
Main Authors: Giulia Marchetti, Paola Nasta, Francesca Bai, Francesca Gatti, Giusi Maria Bellistrì, Camilla Tincati, Federica Borghi, Giampiero Carosi, Massimo Puoti, Antonella d'Arminio Monforte
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3283684?pdf=render

Internet

http://europepmc.org/articles/PMC3283684?pdf=render

Similar Items